The Cabinet Committee on Economic Affairs approved the continuation of the Prime Minister Street Vendor's AtmaNirbhar Nidhi (PM SVANidhi) scheme till December 2024.
Expert panel of the Drug Controller General of India (DCGI) has recommended granting emergency use authorisation for Corbevax for children in the 5 to 12 years age group.
The International Monetary Fund (IMF) has slashed the gross domestic product (GDP) growth forecast for India in FY23 to 8.2 percent in its latest World Economic Outlook report, released.
EXAMIANS